Skip to content
← Holders

Samsara Biocapital, LLC

What Samsara Biocapital, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1744967 · Filed Nov 16, 2026

Positions
27
Reported value
$1.1B
Opened
4
Closed
1
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$765.9M
    27 positions
  2. Dec 31, 2025$969.3M
    21 positions
  3. Mar 31, 2026$1B
    22 positions
  4. Jun 30, 2026$1.2B
    24 positions
  5. Sep 30, 2026$1.1B
    27 positions
SecuritySharesChangeValueOf portfolio
SRRKScholar Rock Holding Corp
6.9M±0%$333.3M31.7%
MLYSMineralys Therapeutics, Inc.
5.9M±0%$147.5M14%
SEPNSepterna, Inc.
3.1M−2.6%$120M11.4%
ALMRAlamar Biosciences, Inc.
2.5M±0%$84.5M8%
SGPSpyGlass Pharma, Inc.
2.1M±0%$54.9M5.2%
ALMSAlumis Inc.
7.2M+14.0%$53.5M5.1%
NGNENeurogene Inc.
1.9M+8.7%$51.9M4.9%
KLRSKalaris Therapeutics, Inc.
12.9M±0%$37.2M3.5%
IVAInventiva S.A.
6.3M±0%$23.3M2.2%
PBLSParabilis Medicines, Inc.
556K±0%$18M1.7%
STROSutro Biopharma, Inc.
1.1M±0%$17.1M1.6%
PMVPPMV Pharmaceuticals, Inc.
7.2MNew$12.1M1.1%
OBXObsidian Therapeutics, Inc.
837.2KNew$11.5M1.1%
AQSTAquestive Therapeutics, Inc.
2.4M−2.6%$11.3M1.1%
VTVTvTv Therapeutics Inc.
354.7K+18.8%$10.9M1%
JBIOJade Biosciences, Inc.
736.2K±0%$10.3M1%
NKTXNkarta, Inc.
3.5M±0%$9.2M0.9%
RANIRani Therapeutics Holdings, Inc.
10.4M±0%$8.2M0.8%
ARTVArtiva Biotherapeutics, Inc.
954.9K±0%$6.8M0.6%
AGMBAgomAb Therapeutics NV
594.7K−0.9%$6.6M0.6%
ELOXEloxx Pharmaceuticals, Inc.
400K±0%$6.1M0.6%
ABVXAbivax S.A.
55.1K±0%$5.5M0.5%
CHRSCoherus Oncology, Inc.
3.4M−1.3%$4.1M0.4%
XFORX4 Pharmaceuticals, Inc
1.3M−3.4%$3.9M0.4%
UPBUpstream Bio, Inc.
300.4K−15.1%$1.6M0.2%
TCGXTCGX Acquisition Corp.
100KNew$1.3M0.1%
GOSSGossamer Bio, Inc.
88KNew$1M0.1%